Catalyst Pharmaceuticals CEO Richard Daly: Big Plans For The Small Biotech Stock investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.
FDA approves Santhera's Duchenne muscular dystrophy drug Agamree pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
CORAL GABLES, Fla., Oct. 16, 2023 (GLOBE NEWSWIRE) Catalyst Pharmaceuticals, Inc. ("Catalyst" or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company, today announced that Patrick J. McEnany, Founder, Chairman and CEO of Catalyst, has been bestowed the 2023 Lifetime Achievement Award by BioFlorida at their Annual Meeting last Friday. This prestigious award highlights Mr. McEnany's outstanding accomplishments, unwavering commitment to rare disease patients, dedication to Cat
By Colin Kellaher Catalyst Pharmaceuticals co-founder Patrick McEnany, who has been at the helm of the drugmaker since its inception in early 2002, plans to.